Novel oral drug therapy combination shows promise for advanced melanoma patients

A research team led by Sheri Holmen, Ph.D., investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the University of Utah (the U), is testing a new combination drug therapy that could both treat and prevent melanoma metastasis, or spreading from its original site, to the brain.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup